Intelligent Bio Solutions (INBS) Stock Price, News & Analysis

Company Overview

Intelligent Bio Solutions Inc. is a life sciences company developing rapid, non-invasive drug-screening technologies. Its primary product is the Intelligent Fingerprinting Drug Screening System, which analyzes sweat collected from a person’s fingerprint to identify the presence of commonly used drugs.

The system combines a disposable drug-screening cartridge with a portable reader and associated software. By using fingerprint sweat rather than blood or urine, the company aims to provide a convenient testing option for organizations such as employers, law-enforcement agencies, drug-treatment providers and other healthcare or public-sector users.

Intelligent Bio Solutions has roots in the development of diagnostic technologies and was formerly known as GBS Inc. The company markets its fingerprint-based screening products internationally, including in the United Kingdom and other markets, subject to applicable regulatory and commercial requirements. The company is led by Chief Executive Officer Harry Simeonidis.

Key Stats

• Today's Range: $1.52 to $1.60
• 50-Day Range: $1.53 to $3.37
• 52-Week Range: $1.52 to $24.90
• Volume: 14,986 shs
• Average Volume: 42,466 shs
• Market Capitalization: $5.08 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Reduce

Intelligent Bio Solutions Stock Analysis - MarketRank™

Intelligent Bio Solutions scored higher than 28% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 1.0 / 5
• Analyst Rating: Reduce

Consensus Rating

Intelligent Bio Solutions has received a consensus rating of Reduce. The company's average rating score is 1.50, and is based on no strong buy ratings, no buy ratings, 1 hold rating, and 1 sell rating.

Amount of Analyst Coverage

Intelligent Bio Solutions has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for Intelligent Bio Solutions are expected to grow in the coming year, from ($5.18) to ($4.06) per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Intelligent Bio Solutions is -0.17, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Intelligent Bio Solutions is -0.17, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Intelligent Bio Solutions has a P/B Ratio of 0.69. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

1.78% of the float of Intelligent Bio Solutions has been sold short.

Short Interest Ratio / Days to Cover

Intelligent Bio Solutions has a short interest ratio ("days to cover") of 1.39, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Intelligent Bio Solutions has recently decreased by 51.24%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Intelligent Bio Solutions does not currently pay a dividend.

Dividend Growth

Intelligent Bio Solutions does not have a long track record of dividend growth.

News and Social Media

• Score: 2.8 / 5
• News Sentiment: 1.45

News Sentiment

Intelligent Bio Solutions has a news sentiment score of 1.45. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.66 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 2 news articles for Intelligent Bio Solutions this week, compared to 2 articles on an average week.

Search Interest

Only 3 people have searched for INBS on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

MarketBeat Follows

Only 1 people have added Intelligent Bio Solutions to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

Company Ownership

• Score: 0.4 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Intelligent Bio Solutions insiders have not sold or bought any company stock.

Percentage Held by Insiders

1.27% of the stock of Intelligent Bio Solutions is held by insiders.

Percentage Held by Institutions

32.97% of the stock of Intelligent Bio Solutions is held by institutions.

Company Calendar

• Last Earnings: 8/19/2026
• Today: 10/11/2026
• Next Earnings (Estimated): 11/11/2026
• Fiscal Year End: 6/30/2027

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Healthcare Equipment & Supplies
• Sub-Industry: Healthcare Equipment
• Current Symbol: NASDAQ:INBS
• Previous Symbol: NASDAQ:GBS
• CIK: 1725430
• Web: www.ibs.inc
• Phone: (646) 790-5756
• Fax: N/A
• Employees: 60
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): ($9.02)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$12.43 million
• Net Margins: -294.88%
• Pretax Margin: -295.82%
• Return on Equity: -175.35%
• Return on Assets: -91.25%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 1.44
• Quick Ratio: 1.35

Sales & Book Value

• Annual Sales: $4.22 million
• Price / Sales: 1.20
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $2.21 per share
• Price / Book: 0.69

Miscellaneous

• Outstanding Shares: 3,320,000
• Free Float: 3,275,000
• Market Cap: $5.08 million
• Optionable: Not Optionable
• Beta: 4.31